Recent News

Jun 13, 2022

Stewardship / Resistance Scan for Jun 13, 2022

Rotavirus vaccine and kids' antibiotic use
MDR-TB treatment in pregnant women
Antibiotic decline in Korea
May 03, 2022
Drug-resistant tuberculosis illustration

WHO calls for shorter drug course for resistant TB

Patients with antibiotic-resistant tuberculosis can be treated with a 6-month, all-oral regimen, the agency says.

Mar 25, 2022
Doctor studying chest x-ray

Reported TB cases drop in US amid COVID-19

Also, the elderly, Black Americans, and those with less education were less likely to use free at-home COVID-19 tests.

Mar 22, 2022
Tuberculosis patient exam

WHO calls for more TB funds, shorter treatment for kids

The new recommendations aim to close a large detection gap in children and teens.

Mar 11, 2022
STOP TB table with information

Trial supports shorter drug regimen for kids with non-severe TB

Data show 4 months of antituberculosis treatment non-inferior to the standard 6-month treatment.

Mar 08, 2022

News Scan for Mar 08, 2022

COVID-19 pneumonia and new dementia
Between-species CWD transmission
COVID-19 and resistant co-infections
Infectious disease risk in Ukrainian refugees
Jan 21, 2022

Stewardship / Resistance Scan for Jan 21, 2022

Oral microbiome therapy for C diff
Funding for new TB treatments
Dec 09, 2021

News Scan for Dec 09, 2021

TB research funds lagging
Avian flu in 3 countries
Oct 22, 2021
TB consultation

New data support shorter regimen for resistant TB

Preliminary data from a phase 3 trial in three countries was released this week at an international conference.

Oct 14, 2021
Tuberculosis prevention efforts

Global TB deaths rise for first time in more than a decade

About 1.5 million people died from tuberculosis in 2020, up from 1.4 million in 2019, and reporting of cases has dropped substantially.

Resources & Literature

Recent Literature

Alene KA, Elagali A, Barth DD, et al. Spatial codistribution of HIV, tuberculosis and malaria in Ethiopia. BMJ Glob Health 2022 Feb 25;7:e007599

Arentz M, Ma J, Zheng P, et al. The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India. BMC Infect Dis 2022 Jan 27;22(92)

Berendsen MLT, Schaltz-Buchholzer F, Bles P, et al. Parental Bacillus Calmette-Guérin vaccine scars decrease infant mortality in the first six weeks of life: a retrospective cohort study. EClinicalMedicine 2021 (published online Aug 11)

Burzynski J, Mangan JM, Lam CK, et al. In-person vs electronic directly observed therapy for tuberculosis treatment adherence: a randomized noninferiority trial. JAMA Netw Open 2022 Jan 20;5(1):e2144210

Carr W, Kurbatova E, Starks A, et al. Interim guidance: 4-month rifapentine-moxifloxacin regimen for the treatment of drug-susceptible pulmonary tuberculosis—United States, 2022. MMWR Morb Mortal Wkly Rep 2022;71(8):285–289

Choi H, Han K, Jung JH, et al. Long-term mortality of tuberculosis survivors in Korea: a population-based longitudinal study. Clin Infect Dis 2022 (published online May 25)

de Macedo Couto R, Santana GO, Ranzani OT, et al. One Health and surveillance of zoonotic tuberculosis in selected low-income, middle-income and high-income countries: a systematic review. PLOS Negl Trop Dis 2022 (published online Jun 6)

Denti P, Wasmann RE, van Rie A, et al. Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study. Clin Infect Dis 2021 (published online Oct 19)

Ding C, Hu M, Guo W, et al. Prevalence trends of latent tuberculosis infection at the global, regional and country levels from 1990 to 2019. Int J Infect Dis 2022 (published online May 13)

Dwyer R, Goosen W, Buss P, et al. Epidemiology of Mycobacterium bovis infection in free-ranging rhinoceros in Kruger National Park, South Africa. Proc Natl Acad Sci USA 2022 Jun 6;119(24):e2120656119

Filardo TD, Feng P, Pratt RH, et al. Tuberculosis — United States, 2021. MMWR Morb Mortal Wkly Rep 2022;71:441-6

Fritschi N, Wind A, Hammer J, et al. Subclinical tuberculosis in children: diagnostic strategies for identification reported in a 6-year national prospective surveillance study. Clin Infect Dis 2021 (published online Aug 19)

Glynn JR, Fielding K, Mzembe T, et al. BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial. Lancet Glob Health 2021 Oct 1;9(10):e1451-9

Kang W, Liu S, Du J, et al. The epidemiology of concurrent extrapulmonary tuberculosis in inpatients with extrapulmonary tuberculosis lesions in China: a large-scale observational multi-center investigation. Int J Infect Dis 2021 (published online Nov 12)

Khan A, Phares CR, Phuong HL, et al. Overseas treatment of latent tuberculosis infection in US–bound immigrants. Emerg Infect Dis 2022 (published online Feb 16)

Kim S, Cohen T, Horsburgh CR Jr, et al. Trends, mechanisms, and racial/ethnic differences of tuberculosis incidence in the US-born population aged 50 years or older in the United States. Clin Infect Dis 2021 (published online Jul 29)

Liu X, Ren N, Ma ZF, et al. Risk factors on healthcare-associated infections among tuberculosis hospitalized patients in China from 2001 to 2020: a systematic review and meta-analysis. BMC Infect Dis 2022 Apr 20;22(392)

Moodley N, Velen K, Saimen A, et al. Digital chest radiography enhances screening efficiency for pulmonary tuberculosis in primary health clinics, South Africa. Clin Infect Dis 2021 (published online Jul 27)

Mtetwa HN, Amoah ID, Kumari S, et al. The source and fate of Mycobacterium tuberculosis complex in wastewater and possible routes of transmission. BMC Public Health 2022 Jan 20;22(145)

Nagot N, Hai VV, Dong TTT, et al. Alarming tuberculosis rate among people who inject drugs in Vietnam. Open Forum Infect Dis 2021 (published online Nov 8)

Nataprawira HM, Gafar F, Risan NA, et al. Treatment outcomes of childhood tuberculous meningitis in a real-world retrospective cohort, Bandung, Indonesia. Emerg Infect Dis 2022 (published online Feb 8)

Nathavitharana RR, Mishra H, Sullivan A, et al. Predicting airborne infection risk: association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers. Clin Infect Dis 2022 (published online Mar 26)

Ndjeka N, Campbell JR, Meintjes G, et al. Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study. Lancet Infect Dis 2022 (published online May 2)

Paradkar MS, Devaleenal DB, Mvalo T, et al. Randomized clinical trial of high dose rifampicin with or without levofloxacin versus standard of care for paediatric tuberculous meningitis: the TBM-KIDS trial. Clin Infect Dis 2022 (published online Mar 15)

Parolina L, Pshenichnaya N, Vasilyeva I, et al. Clinical characteristics of COVID-19 in TB patients and factors associated with the disease severity. Int J Infect Dis 2022 (published online Apr 25)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»